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The reduced folate carrier (RFC), a bidirectional anion transporter, is the major uptake route of reduced folates essential for a spectrum of biochemical reactions and thus cellular proliferation. However, here we show that ectopic overexpression of the RFC, but not of folate-receptor α (FRα), a high-affinity unidirectional folate uptake route serving here as a negative control, resulted in a ~15-fold decline in cellular viability in medium lacking folates, but not in folate-containing medium. Moreover, in order to explore possible mechanisms of adaptation to folate deficiency in various cell lines that express the endogenous RFC, we first determined the gene expression status of the following genes: a) RFC, b) ATPdriven folate exporters (i.e. MRP1, MRP5 and BCRP), c) Folylpoly-γ-glutamate synthetase (FPGS) and γ-glutamate hydrolase (GGH), enzymes catalyzing folate polyglutamylation and hydrolysis, respectively. Upon 3-7 days of folate deprivation, semi-quantitative RT-PCR analysis revealed a specific ~2.5-fold decrease in RFC mRNA levels in both breast cancer and T-cell leukemia cell lines which was accompanied with a consistent fall in methotrexate influx, serving here as a RFC transport activity assay. Likewise, a 2.4-fold decrease in GGH mRNA levels and ~19% decreased GGH activity was documented for folate deprived breast cancer cells. These results along with those of a novel mathematical bio-modeling devised here suggest that upon severe short term (i.e. up to 7 days) folate deprivation, RFC transport activity becomes detrimental as RFC, but not ATPdriven folate exporters, efficiently extrudes folate monoglutamates out of cells. Hence, downregulation of RFC and GGH may serve as a novel adaptive response to severe folate deficiency.
Reduced folate cofactors play an essential role as one-carbon donors and acceptors in several crucial intracellular metabolic reactions [1] [2] [3] [4] [5] [6] ; However, mammalian cells are devoid of the enzymatic capacity for folate biosynthesis and thus are absolutely dependent on folate uptake from exogenous dietary sources [7] . Therefore, folate deficiency may impair the de novo biosynthesis of purines and thymidylate and thereby disrupt DNA and RNA metabolism, homocysteine remethylation, methionine biosynthesis and subsequent formation of S-adenosylmethionine, the universal methyl donor, which in turn may lead to the impairment of methylation reactions [1] [2] [3] [4] [5] [6] . Based on their key role in cellular metabolism, folate cofactors are efficiently retained in cells via polyglutamylation, an ATP-dependent reaction in which up to 9 equivalents of glutamate units are added to the γ-carboxyl residue of folate cofactors [8, 9] (Fig.  1A) . Whereas this reaction is catalyzed by the enzyme folylpoly-γ-glutamate synthetase (FPGS) [9] , the enzyme γ-glutamyl hydrolase (GGH) catalyzes the hydrolysis of these terminal γ-glutamyl residues from polyglutamylated folates [10] . Importantly, the long chain (n>3) folate polyglutamylate derivatives can no longer be extruded via ATP-dependent efflux transporters such as the multidrug resistance proteins (MRPs/ABCCs) [11, 12] , breast cancer resistance protein (BCRP/ABCG2) [13] as well as through the reduced folate carrier (RFC), a bi-directional folate transporter [14] . The molecular mechanisms underlying adaptation to folate deficiency are generally associated with alterations in folate uptake, ATP-driven folate efflux, intracellular folate retention and folatedependent metabolism. These mechanisms include: a) Altered activity of various folate-dependent enzymes including dihydrofolate reductase (DHFR) [15] and thymidylate synthase (TS) [16] , b) Augmented polyglutamylation via increased FPGS activity [17, 18] , c) Overexpression of folate influx systems including the RFC (SLC19A1) [16, 19] and the folate receptor (FR) [15, 17, 20] , d) Downregulation of ATP-dependent folate exporters of the MRP/ABCC family [21, 22] as well as BCRP/ABCG2 [18, 23] . RFC, the main focus of this study, serves as the major uptake route of folates in mammalian cells [14] . Whereas RFC exhibits a relatively wide pattern of tissue expression, the expression of the additional folate uptake systems including the FR family [19, [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] and the proton-coupled folate transporter (PCFT/SLC46A1 ) [36] [37] [38] [39] [40] , both of which are unidirectional transport systems, is rather restricted to a limited number of tissues. Consistently, in vivo studies revealed that whereas RFC-null embryos died in utero prior to embryonic day 9.5 (E9.5), the rescue of the nullizygous embryonic lethal phenotype was achieved by supplementation of pregnant monoallelic RFC dams with 1 mg daily subcutaneous doses of folic acid [41] . Furthermore, the rescued RFC nullizygous embryos died within 12 days after birth due to a failure of hematopoietic organs [41] . RFC functions as a bi-directional anion exchanger [36, 42] with a high affinity (K m =1 µM) for reduced folates and hydrophilic antifolates such as methotrexate (MTX; K m =5-10 µM) but very low affinity (K m =200-400 µM) for folic acid [42] [43] [44] . RFC can neither bind nor hydrolyze ATP in order to drive its folate transport activity across the plasma membrane. Rather, the RFC-dependent uphill influx of folates is coupled to the downhill efflux of organic phosphates including thiamine monophosphate and pyrophosphate [45] that are readily available in the cytoplasm. In the current study we hypothesized that under conditions of severe folate deprivation, the folate efflux component of RFC transport activity may result in intracellular folate depletion and consequently decreased cellular viability. Based upon experimental results as well as on novel mathematical bio-simulation data, we show here for the first time that upon short-term (i.e. up to 7 days) exposure of cells to folate-free growth conditions, RFC-dependent folate efflux activity becomes detrimental as RFC extrudes folate monoglutamates out of cells, a process facilitated by the GGHdependent conversion of folate polyglutamates to monoglutamates. Moreover, this cytotoxic folate efflux activity may be abrogated by specific adaptive down-regulation of both RFC and GGH via decreased gene expression and subsequently decreased catalytic activities; indeed, this novel survival response to folate deprived conditions has been established here for T-cell leukemia CEM/7A cells with overexpression of the endogenous RFC [19] as well as for the breast cancer MCF7/MR cells which expresses only moderate levels of this double-edged sword transporter. supplemented with 2.3 µM folic acid), C5/RFC3nMLCV (i.e. supplemented with 3nM leucovorin which was used as a folate source because of its high affinity to the RFC when compared to folic acid), C5/FR-3nMFA (i.e. supplemented with 3nM folic acid which was used as a folate source because of its high affinity to the FRα when compared to LCV). All the 6 flasks were simultaneously incubated for 6 days in a humidified CO 2 incubator without medium replenishment in each of three independent experiments. Following these 6 days of incubation, cells were detached by trypsinization and the number of viable cells was determined by a haemocytometer counting after trypan blue staining. Folate deprivation-The following are the folate deprivation protocols that we have developed for the following cell lines in order to explore possible mechanisms of adaptation to folate deficiency: A) MCF-7/MR cells (with moderate levels of the RFC): MCF-7/MR cells were grown as previously described [18] . Following trypsinization, cells were washed three times with folic acid-free growth medium containing 10% dialyzed FCS and antibiotics. Then, cells (2.3x10 5 ) were seeded in each of two T75 flasks in 15 ml folic acid-free growth medium; the subline in the first flask was therefore termed MCF-7/MR-NF whereas the second flask was supplemented with 2.3 µM folic acid and was thus termed MCF-7/MR-HF. [19] : CEM/7A cells were cultured in growth medium containing 0.2 nM LCV as has been previously described [19] . Cells were then washed three times with folic acid-free growth medium containing 10% dialyzed FCS and antibiotics and transferred (10 7 cells) to each of two T75 flasks in 50 ml folic acidfree growth medium containing 10% dialyzed FCS and antibiotics; the subline in the first flask was termed CEM/7A-NF whereas the second T75 flask was supplemented with 0.2 nM leucovorin (LCV) and was therefore termed CEM/7A-HF. Following 3 days of, cells were then ready for the various analyses as mentioned above. RNA extraction and semi-quantitative RT-PCRTotal RNA extraction followed by cDNA synthesis was undertaken as previously described [47] . In order to evaluate the levels of β-ACTIN,GAPDH, BCRP, MRP5, MRP1, GGH, FPGS,PCFT,FRα and RFC gene expression, semi-quantitative RT-PCR analysis was used. PCR was carried out in a total volume of 30 µl in the presence of the following cDNA quantities (using 6-fold serial template dilutions): 100, 16.7 and 2.8 ng. Each PCR reaction contained 0.4 µM of the sense and antisense primers ( Table I [46] . The advantage of using MTX rather than folic acid is its 40-80 fold higher affinity to RFC when compared to folic acid, [42] [43] [44] . GGH activity assayCatalytic GGH activity assay was measured according to the original protocol described by O'Connor et al [48] with some slight modifications [49] . These protocols are based on the ability of GGH to convert MTX-Glu 2 to MTX [48, 49] . GGH activity is expressed as nmol MTX formed per hr/mg protein.
Experimental Procedures
Mathematical bio-modeling of intracellular folate depletionHere we devised a mathematical bio-modeling aimed at evaluating the intracellular folate pool depleting effect of the RFC as well as of several representatives of the ABC (ATP-binding cassette) transporter superfamily (i.e. MRP3 and MRP4) under folate free growth conditions (Fig. 1B) . The abovementioned folate efflux systems transport intracellular monoglutamylated folates to the extracellular compartment which is literally infinite relative to the intracellular volume. Thus, the influx of the transported folates is negligible and can be omitted in the model. We applied the MichaelisMenten (M-M) equations (Michaelis and Menten, 1913) in order to simulate these efflux transport activities. Hence, the efflux velocity (v) can be derived from the basic enzymatic reaction kinetics where a substrate S is converted to a product P as follows: 
This is a separable differential equation, hence:
Integration of both sides of the equations results in: [19] and the reported cell volume for CCRF-CEM cells which is 4 x 10 -10 ml/cell [36] . We found that the typical maximal capacity (i.e. V max ) of folate efflux in these mammalian cells is exactly 1 µM/min. During previous studies, a reduction of 60% in the folic acid efflux rate constant was documented in the presence of the RFC transport inhibitor, Nhydroxysuccinimide ester of MTX (NHS-MTX) [21] . Therefore, the estimated capacity of RFC is 0.6 µM/min whereas the remaining folate efflux systems have a cellular folate efflux capacity of 0.4 µM/min. These estimated folate efflux capacities were used to evaluate the folate efflux contribution of RFC relative to the remaining ATP-driven folate efflux systems in the current bio-simulation. However, in order to thoroughly investigate the folate depleting nature of these efflux transporters, four hypothetical efflux capacities were used for several transporters as follows: 1) 1 µM/min 2) 10 and MRP4 with K m = 0.64mM for reduced folates [53, 54] . These representatives of the ABC transporters have been chosen because of available kinetic data (i.e. K m ) for the reduced folate derivatives that serve as the dominant intracellular folate fraction. The various graphs have been plotted in a single coordinate system using the Graph 4.3 software. Statistical Analysis -We used a paired student's Ttest to examine the significance of the difference between two populations for a certain variable. A difference between the averages of two populations was considered significant if the P-value obtained was < 0.05.
RESULTS AND DISCUSSION
In mammalian cells, the transport of THF cofactors (i.e. tetrahydrofolate , a reduced folate derivative) proceeds primarily via the RFC, a high affinity transporter of naturally occurring reduced folates (e.g. Km=1µM for 5-methylTHF). RFC is a nonconcentrative, facilitative transporter with the characteristics of a bi-directional anion exchanger that equally displays influx and efflux of reduced folates. We hence postulated here that the high affinity folate efflux activity component of the RFC may be detrimental to cells subjected to folate-free conditions. The rationale behind this hypothesis was that under these conditions of folatedeprivation, RFC would extrude reduced folate monoglutamates out of cells. Given the lack of folates in the extracellular medium under conditions of severe folate deprivation along with the high affinity RFC-dependent efflux of folate monoglutamates as well as based upon the Le Chatelier principle, one could predict a continuous conversion of intracellular folate polyglutamates to monoglutamate congeners via lysosomal GGH activity (Fig. 1B) . This should result in the continuous efflux of folate monoglutamates via RFC thereby leading to decreased intracellular folate pool and consequent loss of cellular viability (Fig. 1B and Fig. 2) . Furthermore, the folate influx component of the RFC becomes useless when folates are absent from the growth medium, hence rendering RFC a high affinity unidirectional folate exporter (Fig. 1B) . To explore this hypothesis that RFC exerts a cytotoxic effect under conditions of folate deficiency, we first compared the viability of three sublines in medium containing or lacking folates; these cell lines included: RFC-null CHO C5 cells, their stable C5/RFC transfectants overexpressing the RFC [46] as well as C5/FR transfectants overexpressing FRα, the latter of which lacks folate efflux activity and thus serves as a negative control to the efflux component of the RFC (Fig. 2) . The principal advantage of using this particular panel of cell lines is that they are devoid of endogenous RFC transport activity [46] . Moreover, in order to investigate the possible cytotoxic effect of the RFC we preferred to use C5/RFC cells with ectopic RFC overexpression driven by a dominant CMV promoter [46] rather than an endogenously overexpressed RFC that may be down-regulated via a protective mechanism and thereby may compromise this cytotoxic effect. The results revealed a similar viability of C5, C5/RFC and C5/FR cells in folate-replete growth medium (i.e. C5-HF, C5/RFC-3nMLCV and C5/FR3nMFA, respectively) (Fig. 2) . In contrast, in folate-free medium, the viability of C5/RFC cells (i.e. C5/RFC-NF), but not C5/FR-NF cells was 14.8-fold decreased (P= 0.025), relative to RFCnull C5 cells (i.e. C5-NF) (Fig. 2) . Therefore, these results strongly suggest that RFC-mediated folate efflux activity is responsible for the deleterious effect on cellular viability under conditions of severe folate deprivation. Whereas RFC transfectant C5/RFC cells were instrumental in demonstrating the cytotoxic effect of RFC under folate deficiency conditions, we further explored possible mechanisms of adaptation to folate deficiency in various cell lines displaying endogenous RFC expression, thus enabling us to identify possible programmed protective response(s) to folate deficiency. Toward this end, we used T-cell leukemia CEM/7A cells with overexpression of the endogenous RFC [19] as well as breast cancer MCF7/MR cells expressesing only moderate RFC levels. The latter cell line was specifically chosen as it co-expresses various folate influx and efflux transporters; we therefore determined which of these folate transporters may be down-or up-regulated upon short-term folate deprivation. Semi-quantitative RT-PCR analysis revealed a specific 2.4-fold (P= 0.01) and 2.6-fold (P= 0.005) decrease in RFC and GGH mRNA levels, respectively, upon 7 days of folate deprivation in breast cancer MCF-7/MR cells (i.e. MCF-7/MR-NF versus MCF-7/MR-HF); 7 days were the minimal duration time of folate deficiency that enabled us to detect a statistically significant difference in the expression of one or more genes in this cell line (Fig. 3) . Similarly, RFC overexpressing CCRF-CEM-7A leukemia cells [19] displayed a specific 2.5-fold decrease (P= 0.009) in RFC mRNA levels after 3 days of incubation in folate-free medium (i.e. CEM/7A-NF versus CEM7A-HF; Fig. 3) ; in these cells, 3 days were the minimal duration time of folate deficiency that yielded a statistically significant difference in RFC gene expression. The stable gene expression status of the additional folate uptake systems including FRα [19, [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] and PCFT [36] [37] [38] [39] [40] (Fig. 3) strongly suggests that the folate efflux component of RFC was detrimental to cells upon folate deficiency rather than its folate influx component. This ~2.5-fold decrease in RFC mRNA levels in both breast cancer cells and T-cell leukemia lines under folate deficiency, was then examined at the transport activity level (Fig. 4) ; the initial rates of [ 3 H]MTX uptake was determined in the two folate deprived cell lines. Consistent with the decreased RFC transcript levels in folate-deprived cells, both MCF-7/MR (expressing low levels of RFC) as well as CCRF-CEM-7A cells (overexpressing the RFC) showed a 49% (P= 0.03) and 44% (P=0.004 ) decrease in the influx of [ Thus, the cytotoxic effect of the RFC upon folate deficient conditions was probably minimized due to the decreased RFC transport activity. Likewise, the 2.4-fold decrease in GGH mRNA levels was accompanied with ~19% decreased GGH activity (P=0.025; Fig. 5A ) for folate deprived MCF-7/MR-NF cells, relative to their folate-replete counterparts. This specific down-regulation of both RFC and GGH gene expression and activity may serve a as novel cellular adaptive-protective response under folate deficient conditions aimed at counteracting the detrimental conversion of folate polyglutamates to monoglutamates and their subsequent high affinity extrusion via the RFC. Further studies are warranted to pin-point the putative RFC and GGH promoter elements that may respond to folate deprivation and thereby result in repression of gene expression in medium lacking folates. The fact that neither of the ATPdriven folate exporters including MRP1, MRP5 and BCRP [11, 12, 53, 55] underwent down-regulation under these folate-deplete conditions (Fig. 3) , suggests an augmented detrimental role for RFCdependent high affinity folate efflux activity, relative to the above ATP-driven, low affinity (e.g. transport Km values for folic in the millimolar range) efflux transporters of the ABC superfamily [53] (Fig 1B and Fig. 6 ). However, in an attempt to provide a comparative quantification of the intracellular folate depleting effect of RFC with those of ATP-driven folate exporters, we devised a novel mathematical bio-modeling (Fig. 6) . The insilico experiments showed 10-and 100-fold decrease in the intracellular folate pool within 8.7 and 17.1 hours under folate free growth conditions, respectively, as a result of the estimated cellular efflux activity of RFC (i.e. 0.6 µM/min, as was calculated in the Experimental Procedures; Fig. 6 ). Furthermore, the activity of RFC resulted in a dramatic contraction in the intracellular folate pool within days (i.e. 10-and 100-fold decrease in the intracellular folate pool within 2.2 and 4.3 days, respectively) if only 10% of the cellular efflux capacity (i.e. 0.1 µM/min) was attributed to this transporter (Fig. 6) . In contrast to RFC, the folate efflux activity of MRP3 and MRP4 resulted in the retention of the vast majority of the intracellular folate pool (i.e. 96% and 89% retention, respectively) after 7 days of incubation in folate free medium (Fig. 6) . This lack of a substantial folate depleting effect was observed even when the complete cellular folate efflux capacity (i.e. 1 µM/min) was attributed to each of the two ABC transporters (Fig. 6) . Hence, these results provide a mechanistic basis for the highly specific downregulation of the cytotoxic efflux activity of the RFC, but not of folate exporters of the ABC superfamily (Fig. 3) that failed to cause any major decrease in the intracellular folate pool (Fig. 6) , upon short term (up to 7 days) folate deprivation. However, the medium term and long term (i.e. weeks and months, respectively) folate depleting effect of several transporters of the ABC superfamily has been previously suggested as detrimental to cells under folate deficient conditions [18, 21, 23] . Indeed, our mathematical bio-modeling reveals that the folate efflux activity of MRP4, as a representative of folate exporters of the ABC superfamily, may be responsible for a 30% decrease in the intracellular folate pool within 3 weeks of exposure to folate free growth conditions; this moderate depleting effect of this ABC transporter may contribute to the detrimental effect of medium term and long term folate deprivation. Collectively, our findings strongly suggest that the bidirectional folate transport activity of RFC is responsible for its double-edged sword impact on folate homeostasis. Moreover, it is possible that the ability to down-regulate RFC and GGH gene expression under states of severe folate deprivation stems from evolutionary roots originating in unicellular organisms and perhaps metazoic ancestral organisms undergoing transient yet frequent states of starvation and severe folate deprivation. One important emerging question from the current study is what physiological-pathological conditions and syndromes could match the transient folate-deprivation conditions used in the current paper. The first pathological syndrome, hereditary folate malabsorption (HFM) [56] , is caused by loss of function mutations in the protoncoupled folate transporter (PCFT/HCP-1/SLC46A1) normally responsible for the high affinity intestinal influx of naturally occurring folates at the acidic microclimate of the upper intestinal mucosal epithelium. Hence, HFM patients suffer from extremely low folate levels (≤ 0.2 nM) in the blood and cerebrospinal fluid (CSF) [40, 56] . Another physiological-pathological condition that may match such severe folate deprivation state includes nutritional folate deficiency or insufficiency. Indeed, folate deficiency affects approximately 10% of the population as well as more than 50% of the children and elderly that live in poverty in the United States, Thailand and rural areas of India [38, 57, 58] . Hence, under such physiologicalpathological conditions of severe folate deficiency, RFC and GGH may possibly undergo a significant down-regulation in gene expression and activity in order to protect cells from further loss of intracellular folates due to folate efflux via the RFC. The current study may have profound implications relating to various disciplines in biology and medicine including: a) Developmental biology and embryonic development-The central developmental role that mammalian RFC plays has been revealed in RFC knockout mice studies [41] ; in contrast to this vital role of the RFC under conditions in which folates are available for the pregnant dams, our findings suggest that under conditions of severe nutritional folate deficiency or insufficiency of mammalian pregnant dams, the RFC may in fact exacerbate the embryos pathological status caused by the folate deficiency by further extruding folates. Thus, RFC may play a key role in inducing early abortions during early stages of mammalian pregnancy when folates are severely limited in the growth environment and thereby may confer an evolutionary advantage by eliminating embryos that are certain to fail normal cell proliferation, differentiation and proper development. b) Molecular medicine-RFC is an important route for the uptake of various antifolates including for example MTX and Pemetrexed (Alimta) [59, 60] ; hence, our findings suggest that the down-regulation of the RFC as a result of folate deficient conditions may decrease antifolate uptake and thus compromise the pharmacological efficacy of antifolates currently used in chemotherapy of various cancers. Moreover, down-regulation and mutational inactivation of the RFC serve as major mechanisms of antifolate drug resistance practiced by cancer cells [47, 59, 61, 62] The CHO cell line deficient in RFC transport activity termed C5 as well as its RFC-and FRoverexpressing transfectants were trypsinized and washed three times with folic acid-free growth medium. Then, cells (6x10 4 ) were seeded in each of two T25 flasks in 5 ml folic acid-free growth medium. The sublines in the first set of flasks were termed C5/NF, C5/FR-NF and C5/RFC-NF (i.e. no folate). The sublines in the second set of flasks were supplemented with folates derivatives according to their initial growth conditions (i.e. 2.3 µM folic acid, 3 nM folic acid and 3 nM LCV) resulting in the sublines C5-HF, C5/FR-3nMFA and C5/RFC-3nMLCV, respectively. All 6 flasks were simultaneously incubated for 6 days in a humidified CO 2 incubator at 37 o C. Following these 6 days of incubation, cells were detached by trypsinization and the number of viable cells was determined by a haemocytometer counting after trypan blue staining. The asterisk denotes a statistically significant difference. : GGH activity in folate supplemented and folate deprived sublines. GGH activity was determined in the folate-supplemented cell lines MCF7/MR-HF and CEM/7A-HF as well as for their folate-deprived counterparts MCF7/MR-NF and CEM/7A-NF, respectively. Note that the asterisk denotes a statistically significant difference whereas the average percentage decrease of GGH activity is depicted within the figure and shown adjacent to the relevant column. Mathematical modeling aimed at evaluating the residual intracellular folate pool (Y axis) in the presence of the following folate efflux transporters: RFC or MRP3 or MRP4; the different maximal folate efflux capacities for each experiment are depicted in a close proximity to its plotted graph or via arrows. The theoretical experiments simulate the cellular folate pool status for duration of up to 7 days (X axis) upon folate free conditions in the presence of one examined folate efflux transporter. Note that the folate depleting effect of the RFC was evaluated in four different efflux capacities including the hypothetical negligible capacities of 1% and 0.1% (i.e. 0.01µM/min and 0.001µM/min, respectively) of the total cellular folate efflux capacity. Figure 1 by guest on September 16, 2017 
